[HTML][HTML] UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α

Y Goto, L Zeng, CJ Yeom, Y Zhu, A Morinibu… - Nature …, 2015 - nature.com
Y Goto, L Zeng, CJ Yeom, Y Zhu, A Morinibu, K Shinomiya, M Kobayashi, K Hirota, S Itasaka…
Nature communications, 2015nature.com
Abstract Hypoxia-inducible factor 1 (HIF-1) plays a role in tumour metastases; however, the
genes that activate HIF-1 and subsequently promote metastases have yet to be identified.
Here we show that Ubiquitin C-terminal hydrolase-L1 (UCHL1) abrogates the von Hippel–
Lindau-mediated ubiquitination of HIF-1α, the regulatory subunit of HIF-1, and consequently
promotes metastasis. The aberrant overexpression of UCHL1 facilitates distant tumour
metastases in a HIF-1-dependent manner in murine models of pulmonary metastasis …
Abstract
Hypoxia-inducible factor 1 (HIF-1) plays a role in tumour metastases; however, the genes that activate HIF-1 and subsequently promote metastases have yet to be identified. Here we show that Ubiquitin C-terminal hydrolase-L1 (UCHL1) abrogates the von Hippel–Lindau-mediated ubiquitination of HIF-1α, the regulatory subunit of HIF-1, and consequently promotes metastasis. The aberrant overexpression of UCHL1 facilitates distant tumour metastases in a HIF-1-dependent manner in murine models of pulmonary metastasis. Meanwhile, blockade of the UCHL1–HIF-1 axis suppresses the formation of metastatic tumours. The expression levels of UCHL1 correlate with those of HIF-1α and are strongly associated with the poor prognosis of breast and lung cancer patients. These results indicate that UCHL1 promotes metastases as a deubiquitinating enzyme for HIF-1α, which justifies exploiting it as a prognostic marker and therapeutic target of cancers.
nature.com